Antibiotic Resistance Perspective

• Why I Don't Worry About Nephrotoxicity With Zosyn   Dr Paul Auwaerter explains why a warning about nephrotoxicity doesn't influence his decision to use Zosyn when it's indicated.
  Medscape Infectious Diseases, December 11, 2023
• 5 Things to Know: Improving Antibiotic Use in Telemedicine CDC's epidemiologist Guillermo Sanchez, PA-C, MSHS, MPH, shares strategies to incorporate antibiotic stewardship into telemedicine appointments.
  CDC Expert Commentary, December 06, 2023
• Laissez-Faire Attitude Toward Infectious Diseases? This doc read some articles recently that raised his concern about the attitude toward treatment and prevention of infectious diseases, and lack of understanding of why we treat our patients.
  MDedge, November 14, 2023
• S2 Episode 6: Pediatric Asthma: When Is It an Emergency?   When is it time to send a child with an asthma exacerbation to the emergency department? Join Drs Michael Wechsler and Todd Florin as they discuss.
  Medscape, November 14, 2023
• IDWeek 2023 Read clinically focused news coverage of key developments from IDWeek 2023
  Medscape Infectious Diseases, October 11, 2023
• Can Zoo Poo Help Manage Diabetic Foot Ulcers? Feces from endangered species could possibly aid in treating diabetic foot ulcers, advancing the treatment considerably, writes David G. Armstrong, DPM, MD, PhD.
  Medscape Diabetes & Endocrinology, October 02, 2023
• Three Cases of Community-Acquired Pneumonia Clinicians should consider all three etiologies on community-acquired pneumonia presentation to improve antimicrobial stewardship and patient outcomes.
  CDC Expert Commentary, September 18, 2023
• CDC's New Program Aims to Help Hospitals Combat Sepsis Medscape spoke with CDC contributors Raymund Dantes, MD, MPH, and Hallie Prescott, MD, MSc, about the new Hospital Sepsis Program Core Elements to help clinicians improve outcomes from sepsis.
  CDC Expert Commentary, September 12, 2023
• Change Makers: Elcin Barker Ergun on Healthcare Renaissance WebMD Chief Medical Officer John Whyte, MD, MPH, speaks with Elcin Barker Ergun, CEO of the Menarini Group, in Florence, Italy, about what they believe to be a new renaissance in healthcare.
  Medscape, September 07, 2023
• Episode 5: Complicated Pediatric Pneumonia   Drs Todd A. Florin and Debra Palazzi discuss complicated pediatric pneumonia: what it is, how to diagnose it, and how to manage it.
  Medscape, August 10, 2023
• New and Emerging Options for Treating Recurrent C difficile   Paul G. Auwaerter, MD, discusses treatment options for recurrent C difficile, including new FDA-approved fecal microbiota products.
  Medscape Infectious Diseases, July 28, 2023
• Episode 4: Treatment Strategies for Pediatric Pneumonia   Drs Todd A. Florin and Derek J. Williams discuss the latest treatment strategies for pediatric pneumonia and challenge the long-standing method of treating pneumonia in children with mild disease.
  Medscape, July 12, 2023
• Respiratory Bacteria in Children Younger Than 6 Months We found two significant risk factors in the first 6 months of life for detection of nasopharyngeal colonization of pneumococcus, H influenzae, and M catarrhalis.
  MDedge, June 16, 2023
• Endemic Melioidosis in the United States Melioidosis from B pseudomallei is now locally endemic to the southern continental United States.
  CDC Expert Commentary, April 21, 2023
• Emergency Risk Communication for Healthcare Professionals The COCA and HAN team at CDC focuses on emergency preparedness and response communication tailored to healthcare professionals.
  CDC Expert Commentary, March 02, 2023
• Young Children Quickly Outgrow the Need for Ear Tubes Dr Michael Pichichero discusses the timing and necessity of tympanostomy tubes for recurrent otitis media in young children.
  MDedge, February 15, 2023
• Advice on Antibiotics For Kids During Shortages Prescribing antibiotics for children with viral infections has led to a shortage of the most commonly used antibiotics.
  CHOP Expert Commentary, February 03, 2023
• Is Bacterial Resistance the Next Pandemic? Fears that a new health policy in the UK increases the risk of emerging bacteria resistance is just one sign that we are still not doing things right.
  Medscape Blogs, November 21, 2022
• IDWeek 2022 Read clinically focused news coverage of key developments from IDWeek 2022
  October 18, 2022
• The Impact of COVID-19 on Antimicrobial Resistance in the US   Arjun Srinivasan, MD, deputy director for program improvement in the division of healthcare quality promotion at the CDC, discusses the impact of COVID-19 on antimicrobial resistance.
  CDC Expert Commentary, September 27, 2022